US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
イギリス
LSE
Novartis Ag (0K9E)
Novartis Ag (0K9E) ニュース

0K9E

Novartis (0K9E)

Novartis Ag

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0K9E

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/01/29	15 : 00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Delivered Strong Sales Growth, Margin Expansion And Breakthrough Innovation Launching Five...	LSE:0K9E	Novartis Ag
2020/01/29	15 : 00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Erzielt 2019 Ein Starkes Umsatzwachstum, Margen-steigerungen Und Bahnbrechende Innovatione...	LSE:0K9E	Novartis Ag
2020/01/29	15 : 00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis A Réalisé En 2019 Une Forte Croissance De Son Chiffre D'affaires, Une Augmentation De Sa...	LSE:0K9E	Novartis Ag
2020/01/06	15 : 00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Completes Tender Offer For All Outstanding Shares Of The Medicines Company	LSE:0K9E	Novartis Ag
2019/12/16	15 : 15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Provides Update On Luster Phase Iii Studies In Patients With Uncontrolled Gina 4/5 Asthma	LSE:0K9E	Novartis Ag
2019/12/05	15 : 00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Tender Offer For The Medicines Company Commences	LSE:0K9E	Novartis Ag
2019/11/25	05 : 00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis To Acquire The Medicines Company For Usd 9.7 Bn, Adding Inclisiran, A Potentially Transfor...	LSE:0K9E	Novartis Ag
2019/11/16	05 : 06	UK Regulatory	NOVARTIS AG CHF0.50(REGD) New Novartis Medicine Adakveo(R) (crizanlizumab) Approved By Fda To Reduce Frequency Of Pain Crises...	LSE:0K9E	Novartis Ag
2019/11/01	15 : 15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Shows Encouraging Results Versus Humira(R)* From First-of-its-kind Head-to-hea...	LSE:0K9E	Novartis Ag
2019/10/30	15 : 00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Announces Avxs-101 Intrathecal Study Update	LSE:0K9E	Novartis Ag
2019/10/22	14 : 00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Delivered Another Strong Quarter With Double Digit Sales Growth And Core1 Margin Expansion...	LSE:0K9E	Novartis Ag
2019/10/22	14 : 00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis, Encore Un Fort Trimestre: Croissance à Deux Chiffres Des Ventes Et Expansion De La Marge...	LSE:0K9E	Novartis Ag
2019/10/22	14 : 00	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Verzeichnet Ein Weiteres Starkes Quartal Mit Zweistelligem Umsatz-wachstum Und Höherer Ke...	LSE:0K9E	Novartis Ag
2019/10/08	14 : 15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Receives Fda Approval For Beovu(R), Offering Wet Amd Patients Vision Gains And Greater Flu...	LSE:0K9E	Novartis Ag
2019/10/02	14 : 15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Positive 52-week Prevent Data Confirm Cosentyx(R) Efficacy In Addressing Entire Axspa Spec...	LSE:0K9E	Novartis Ag
2019/09/29	23 : 30	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Kisqali(R) Delivers Consistently Superior Overall Survival -- Monaleesa-3 Trial Demonstrat...	LSE:0K9E	Novartis Ag
2019/09/17	14 : 15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Positive 16-week Prevent Results Advance Potential New Indication For Patients...	LSE:0K9E	Novartis Ag
2019/08/30	14 : 15	UK Regulatory	NOVARTIS AG CHF0.50(REGD) Novartis Ofatumumab Demonstrates Superiority Versus Aubagio(R) In Two Head-to-head Phase Iii Multip...	LSE:0K9E	Novartis Ag

Showing the most relevant articles for your search:LSE:0K9E

1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約